Hap Trading, LLC Igm Biosciences, Inc. Call Options Transaction History
Hap Trading, LLC
- $935 Billion
- Q1 2025
Call Options
3 transactions
Others Institutions Holding IGMS
# of Institutions
82Shares Held
16.2MCall Options Held
26.8KPut Options Held
800-
Baker Bros. Advisors LP New York, NY4.1MShares$4.79 Million0.06% of portfolio
-
Siren, L.L.C. New York, NY3.26MShares$3.81 Million0.21% of portfolio
-
Redmile Group, LLC San Francisco, CA2.95MShares$3.45 Million0.36% of portfolio
-
Black Rock Inc. New York, NY883KShares$1.03 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA876KShares$1.02 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $33.9M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...